155 related articles for article (PubMed ID: 24380320)
1. [Closed-loop management model of clinical investigational product for new drug of traditional Chinese medicine].
Wu P; Zhang JW
Zhongguo Zhong Yao Za Zhi; 2013 Sep; 38(17):2898-900. PubMed ID: 24380320
[TBL] [Abstract][Full Text] [Related]
2. [Characteristics and difficulties in clinical trials of new traditional Chinese drugs].
Wang HN
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Jul; 27(7):650-2. PubMed ID: 17717932
[TBL] [Abstract][Full Text] [Related]
3. [Situation analysis for drug clinical trial institutions].
Chen YY; Wu P; Wang J
Zhongguo Zhong Yao Za Zhi; 2014 Aug; 39(16):3208-10. PubMed ID: 25509318
[TBL] [Abstract][Full Text] [Related]
4. [Significance of re-evaluation and development of Chinese herbal drugs].
Gao Y; Ma Z; Zhang B
Zhongguo Zhong Yao Za Zhi; 2012 Jan; 37(1):1-4. PubMed ID: 22741451
[TBL] [Abstract][Full Text] [Related]
5. [Clinical orientation of post-marketing Chinese patent drugs: an evidence-based practice].
Shang HC; Zhang BL; Li YP
Zhong Xi Yi Jie He Xue Bao; 2008 Sep; 6(9):887-90. PubMed ID: 18782528
[TBL] [Abstract][Full Text] [Related]
6. [Status and thinking of supervision and management of Chinese herbal medicine].
Xie XY
Zhongguo Zhong Yao Za Zhi; 2013 Jun; 38(11):1832-5. PubMed ID: 24010306
[TBL] [Abstract][Full Text] [Related]
7. [Some points on clinical evaluation of new Chinese herbal drugs].
Ma K; Li LD
Zhongguo Zhong Yao Za Zhi; 2004 May; 29(5):489-91. PubMed ID: 15706907
[TBL] [Abstract][Full Text] [Related]
8. [Traditional Chinese medicine injection clinical use management model for evaluation].
Liu F; Ma R; Liao X; Chai SW
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2752-5. PubMed ID: 23285927
[TBL] [Abstract][Full Text] [Related]
9. [Specificity of traditional Chinese medicine's clinical re-evaluation].
Li LD; Li YK; Li FJ
Zhongguo Zhong Yao Za Zhi; 2014 Jan; 39(1):3-4. PubMed ID: 24754158
[TBL] [Abstract][Full Text] [Related]
10. Asian medicine. The new face of traditional Chinese medicine.
Normile D
Science; 2003 Jan; 299(5604):188-90. PubMed ID: 12522228
[No Abstract] [Full Text] [Related]
11. [Some issues to notice in the research and quality evaluation of external preparations of traditional Chinese medicine].
Jin F
Zhongguo Zhong Yao Za Zhi; 2010 Nov; 35(21):2934-6. PubMed ID: 21322963
[TBL] [Abstract][Full Text] [Related]
12. [Key points for clinical orientation in the secondary development of famous and superior Chinese patent drugs].
Shang HC; Liu Y; Zhang JH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Oct; 28(10):939-40. PubMed ID: 19123337
[TBL] [Abstract][Full Text] [Related]
13. [Problems in preparation of toxic herbs in process of research and development of new traditional Chinese medicine of rheumatism, orthopedics and surgery].
Wang T; Zhou G
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(17):2653-5. PubMed ID: 23236771
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on reasons for disapproval of registration application of new traditional Chinese medicines in recent years].
Zhang X; Zhang L; Wang H
Zhongguo Zhong Yao Za Zhi; 2012 Aug; 37(15):2333-7. PubMed ID: 23193572
[TBL] [Abstract][Full Text] [Related]
15. Are national quality standards for traditional Chinese herbal medicine sufficient? Current governmental regulations for traditional Chinese herbal medicine in certain Western countries and China as the Eastern origin country.
Dobos GJ; Tan L; Cohen MH; McIntyre M; Bauer R; Li X; Bensoussan A
Complement Ther Med; 2005 Sep; 13(3):183-90. PubMed ID: 16150372
[TBL] [Abstract][Full Text] [Related]
16. Biochemistry. Lifting the veil on traditional Chinese medicine.
Stone R
Science; 2008 Feb; 319(5864):709-10. PubMed ID: 18258866
[No Abstract] [Full Text] [Related]
17. [A discussion of key issues on postmarketing reevaluation of Chinese medicine].
Xie Y; Tian F
Zhongguo Zhong Yao Za Zhi; 2010 Jun; 35(11):1494-7. PubMed ID: 20822029
[TBL] [Abstract][Full Text] [Related]
18. [Research on establishment of clinical safety intensive hospital monitoring net of traditional Chinese medicine injection].
Wang LX; Xie YM; Wang ZF
Zhongguo Zhong Yao Za Zhi; 2012 Sep; 37(18):2692-4. PubMed ID: 23285910
[TBL] [Abstract][Full Text] [Related]
19. [Current status, problems and countermeasures for properties theory of Chinese medicinal herbs].
Zhang D; Gao X; Zhong G; Zhang J
Zhongguo Zhong Yao Za Zhi; 2009 Sep; 34(18):2400-4. PubMed ID: 20030098
[TBL] [Abstract][Full Text] [Related]
20. FDA's proposed regulations to expand access to investigational drugs for treatment use: the status quo in the guise of reform.
Rossen BR
Food Drug Law J; 2009; 64(1):183-223. PubMed ID: 19998746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
